Health
Metformin treatment linked to slowed cognitive decline – EurekAlert
A six-year study of older Australians with type 2 diabetes has uncovered a link between metformin use, slower cognitive decline and lower dementia rates.
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels.
A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 diabetes who used metformin experienced slower cognitive decline with lower dement…
-
Noosa News16 hours agoForum responds to urgent homelessness issues in Nambour
-
Noosa News15 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General15 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers
-
Business14 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?